[go: up one dir, main page]

ATE24933T1 - Biologisch wirksame verbindungen ws 6049, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen. - Google Patents

Biologisch wirksame verbindungen ws 6049, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen.

Info

Publication number
ATE24933T1
ATE24933T1 AT83104988T AT83104988T ATE24933T1 AT E24933 T1 ATE24933 T1 AT E24933T1 AT 83104988 T AT83104988 T AT 83104988T AT 83104988 T AT83104988 T AT 83104988T AT E24933 T1 ATE24933 T1 AT E24933T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
biologically active
processes
production
active compounds
Prior art date
Application number
AT83104988T
Other languages
English (en)
Inventor
Sumio Kiyoto
Motoaki Nishikawa
Morita Iwami
Hiroshi Terano
Masanobu Kohsaka
Hiroshi Imanaka
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE24933T1 publication Critical patent/ATE24933T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/03—Actinomadura
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/825—Actinomadura

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
  • Light Receiving Elements (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AT83104988T 1982-05-24 1983-05-20 Biologisch wirksame verbindungen ws 6049, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen. ATE24933T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8215123 1982-05-24
EP83104988A EP0095154B1 (de) 1982-05-24 1983-05-20 Biologisch wirksame Verbindungen WS 6049, Verfahren zu deren Herstellung und deren pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE24933T1 true ATE24933T1 (de) 1987-01-15

Family

ID=10530585

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83104988T ATE24933T1 (de) 1982-05-24 1983-05-20 Biologisch wirksame verbindungen ws 6049, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen.

Country Status (11)

Country Link
US (1) US4578271A (de)
EP (1) EP0095154B1 (de)
JP (2) JPS58212787A (de)
KR (1) KR900004066B1 (de)
AT (1) ATE24933T1 (de)
AU (1) AU565322B2 (de)
CA (1) CA1209935A (de)
DE (1) DE3369158D1 (de)
DK (1) DK232483A (de)
ES (1) ES522637A0 (de)
SU (1) SU1308200A3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78648B (de) * 1982-07-26 1984-09-27 Bristol Myers Co
US4675187A (en) * 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
JPS606194A (ja) * 1983-06-23 1985-01-12 Meiji Seika Kaisha Ltd 新規抗生物質ｓｆ−２２８８及びその製造法
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production
US4868117A (en) * 1984-04-20 1989-09-19 Bristol-Myers Company BBM-1675, a new antitumor antibiotic complex
US4554162A (en) * 1984-05-04 1985-11-19 Warner-Lambert Company CL-1724 Antibiotic compounds, their production and use
GB8425685D0 (en) * 1984-10-11 1984-11-14 Lepetit Spa Antibiotic a 40926 complex
US5427941A (en) * 1985-08-08 1995-06-27 Schering Corporation Actinomadura brunnea var. antibiotica strains
IL79519A0 (en) * 1985-08-27 1986-10-31 Bristol Myers Co Bbm-1675c and d antitumor antibiotics
US4837206A (en) * 1987-04-29 1989-06-06 Bristol-Myers Company Esperamicin derivatives
US4916065A (en) * 1988-06-10 1990-04-10 Bristol-Myers Company BU-3420T Antitumor antibiotic
US4952572A (en) * 1988-06-10 1990-08-28 Bristol-Myers Company BU-3420T antifungal antibiotic
US5116845A (en) * 1990-05-04 1992-05-26 Bristol-Myers Company BU-3420T antitumor antibiotic
WO2003062458A2 (en) * 2002-01-24 2003-07-31 Ecopia Biosciences Inc. Method, system and knowledge repository for identifying a secondary metabolite from a microorganism
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
EP1565201B1 (de) 2002-11-18 2018-10-31 Vicuron Pharmaceuticals, Inc. Methoden zur verabreichung von dalbavancin zur behandung bakterieller infektionen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195079A (en) * 1979-01-31 1980-03-25 Pfizer Inc. New polycyclic ether antibiotic
JPS56113791A (en) * 1980-02-15 1981-09-07 Kaken Pharmaceut Co Ltd Novel antibiotic and its preparation

Also Published As

Publication number Publication date
ES8501440A1 (es) 1984-12-01
DE3369158D1 (en) 1987-02-19
DK232483D0 (da) 1983-05-24
EP0095154B1 (de) 1987-01-14
DK232483A (da) 1983-11-25
CA1209935A (en) 1986-08-19
KR900004066B1 (ko) 1990-06-11
AU1488683A (en) 1983-12-01
SU1308200A3 (ru) 1987-04-30
AU565322B2 (en) 1987-09-10
JPS58212787A (ja) 1983-12-10
JPH02257886A (ja) 1990-10-18
JPH0415236B2 (de) 1992-03-17
ES522637A0 (es) 1984-12-01
JPH0216756B2 (de) 1990-04-18
KR840004783A (ko) 1984-10-24
EP0095154A1 (de) 1983-11-30
US4578271A (en) 1986-03-25

Similar Documents

Publication Publication Date Title
ATE24933T1 (de) Biologisch wirksame verbindungen ws 6049, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen.
DE69023934D1 (de) Substanz PF 1022, Verfahren zu ihrer Herstellung und diese Substanz enthaltende anthelmintische Zusammensetzung.
ATE36699T1 (de) Chinonderivate, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung.
DE3778219D1 (de) Valproe- und (e)-2-valproensaeureabkoemmlinge, verfahren zu deren herstellung und pharmazeutische zusammensetzungen davon.
ATE123529T1 (de) Substanzen ws 7622 a,b,c und d, deren derivate, verfahren zu deren herstellung sowie deren verwendung.
GB1500965A (en) Cyclic ether antibiotics
DE3862196D1 (de) Ein doxorubicinderivat, ein verfahren zu dessen herstellung, pharmazeutische zusammensetzungen und dessen verwendung fuer die herstellung von arzneimitteln.
JPS56125397A (en) Oligosaccharide derivative, its preparation and preventing agent against decayed tooth containing the same as active constituent
ATE55153T1 (de) Ws-7739-verbindungen, deren herstellung und deren pharmazeutische zusammensetzung.
JPS51118883A (en) Process for cultivation microorganisms aerobically and its apparatus
DE69113772D1 (de) 1,4-benzodioxanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
JPS5692789A (en) Fungus polyamine oxidase pc-3 and its preparation
FR2518571B1 (fr) Agent de decomposition de la remanence vegetale, procede de preparation d'une proteine vegetale purifiee utilisant cet agent et proteine vegetale purifiee ainsi obtenue
JPS52269A (en) Process for preparing 5-amino-4-imidazole carboxamide and d-ribose
JPS5399397A (en) Method for preparing amino acids, nucleic acids or organic acids
JPS5462392A (en) Preparation of antibiotic substance, sisomicin
JPS54128575A (en) Novel pentalenonelactone compound and drugs comprising it as active constituent
JPS51151395A (en) Process for preparing a biologically active substance, ps46-b1
JPS56125396A (en) Protein an-1
JPS57166986A (en) Preparation of antibiotic substance
JPS643132A (en) Production of 5-alkylydene norbornene
JPS5598115A (en) Bacteriolytic agent for gram-negative bacteria
ATE110781T1 (de) Physiologisch aktive verbindungen sn-198c sowie verfahren und bakterien zu deren herstellung.
JPS54129182A (en) Production of bacterial cells
JPS5462393A (en) Preparation of antibiotic substance, verdamicin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee